Fig. 6

The tricho-rhino-phalangeal syndrome 1 (TRPSI)-ubiquitin-specific protease 4 (USP4)-histone deacetylase 2 (HDAC2) regulatory axis confers growth in cancer cells in vitro and in xenografted tumors in vivo. a MCF7 shows decreased cell viability upon silencing of TRPS1 and additional overexpression of HDAC2 restored cell viability. b MCF7 shows decreased cell viability upon silencing of USP4 and additional overexpression of HDAC2 restored cell viability. c Xenografted tumor growth curves (left), xenografted tumor weight (right). d Representative xenografted tumors from mouse models. e Representative western blot data of selected xenografted tumors show TRPS1 and myc-HDAC2 protein levels. f A working model of the current study. The t test was used for statistic quantifications: *p < 0.05, **p < 0.01, ***p < 0.001, respectively. siRNA, small interfering RNA